FdaApplication
ANDA 208663
Identifiers
- fda_app_no: ANDA208663
Properties
| Property | Value |
|---|---|
| applicant_name | STERIMAX INC |
| application_type | ANDA |
| approval_date | 2020-06-09 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ETHACRYNATE SODIUM | ETHACRYNATE SODIUM | EQ 50MG BASE/VIAL | INJECTABLE;INJECTION |
1 product